GP7 Stock Chart & Stats
€36.00
-€0.40(-1.09%)
At close: 4:00 PM EDT
€36.00
-€0.40(-1.09%)
Day’s Range― - ―
52-Week Range€24.80 - €40.80
Previous CloseN/A
Volume0.00
Average Volume (3M)35.00
Market Cap
€2.00B
Enterprise Value€3.18K
Total Cash (Recent Filing)€996.71M
Total Debt (Recent Filing)€1.41B
Price to Earnings (P/E)15.4
Beta0.15
Next Earnings
Nov 30, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.70
Shares Outstanding9,650,221
10 Day Avg. Volume0
30 Day Avg. Volume35
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)1.32
Price to Sales (P/S)0.67
P/FCF Ratio7.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€42.62Price Target Upside18.40% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)2.58
Revenue Forecast (FY)€2.61B
Bulls Say, Bears Say
Bulls Say
Improved ProfitabilityImproved gross and net margins show stronger current earnings conversion despite a softer top line. If sustained, better profitability can support reinvestment, strengthen resilience against cost pressure, and provide more flexibility for debt reduction or strategic growth.
Moderate, Improving LeverageThe reduction in leverage indicates progress in strengthening the capital structure, while steady returns on equity show the business continues to generate reasonable profitability from its asset base. This combination supports financial flexibility over the next several quarters.
European Pet ExpansionThe proposed TRIXIE acquisition could broaden Central’s international revenue base and deepen its position in pet supplies, while combining Central’s scale with TRIXIE’s innovation and logistics. Retained ownership and continuing management involvement may support continuity and integration.
Bears Say
Persistent Revenue DeclineOngoing revenue contraction indicates limited volume and pricing momentum across the portfolio, which can constrain operating leverage and make margin improvement harder to sustain. Continued top-line weakness may also reduce the resources available for reinvestment and strategic expansion.
Weakening Free Cash FlowAlthough cash generation remains positive, the sharp free-cash-flow decline reduces the cushion available for debt reduction, buybacks, acquisitions, and reinvestment. If the downtrend persists alongside softer demand, Central may have less flexibility to absorb operating or integration pressures.
Debt Remains SizableImproving leverage is offset by a still-substantial absolute debt load relative to the equity base and earnings capacity. This can make financial results more sensitive to weaker demand or cost inflation, while limiting capital-allocation flexibility during a prolonged downturn.
GP7 FAQ
What was Central Garden & Pet’s price range in the past 12 months?
Central Garden & Pet lowest stock price was €24.80 and its highest was €40.80 in the past 12 months.
What is Central Garden & Pet’s market cap?
Central Garden & Pet’s market cap is €2.00B.
When is Central Garden & Pet’s upcoming earnings report date?
Central Garden & Pet’s upcoming earnings report date is Nov 30, 2026 which is in 83 days.
How were Central Garden & Pet’s earnings last quarter?
Central Garden & Pet released its earnings results on Aug 05, 2026. The company reported €1.333 earnings per share for the quarter, beating the consensus estimate of €1.326 by €0.007.
Is Central Garden & Pet overvalued?
According to Wall Street analysts Central Garden & Pet’s price is currently Undervalued.
Does Central Garden & Pet pay dividends?
Central Garden & Pet does not currently pay dividends.
What is Central Garden & Pet’s EPS estimate?
Central Garden & Pet’s EPS estimate is -0.05.
How many shares outstanding does Central Garden & Pet have?
Central Garden & Pet has 9,650,221 shares outstanding.
What happened to Central Garden & Pet’s price movement after its last earnings report?
Central Garden & Pet reported an EPS of €1.333 in its last earnings report, beating expectations of €1.326. Following the earnings report the stock price went up 2.235%.
Which hedge fund is a major shareholder of Central Garden & Pet?
Currently, no hedge funds are holding shares in DE:GP7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Central Garden Pet Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€42.62 (18.40% Upside)
€42.62 (18.40% Upside)
Blogger Sentiment
Bullish
DE:GP7 Sentiment 80%
Sector Average 60%
Sector Average 60%
Insider Transactions
Sold Shares
Worth €466.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.98%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.63%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Central Garden & Pet
Central Garden & Pet Company (“Central”) is a market leader in the U.S. pet and garden industries. The company operates through two reportable segments: Pet and Garden. Its Pet segment offers a broad range of products for dog and cat supplies, including treats and chews, toys, and grooming items. The Garden segment includes products like grass seed, wild bird feed, weed and insect control, and fertilizers under brands such as Pennington and Sevin.
GP7 Company Deck
GP7 Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a largely positive operating and financial picture: record Q2 and first-half results, top-line growth (+9% consolidated), margin expansion, improved adjusted EBITDA, strong segment performance (Pet +5%, Garden +13% in Q2), and a robust balance sheet. Strategic simplification and the Phillips JV position the company to focus on higher-margin branded growth, though the JV will reduce reported revenue in the near term and bring a modest initial EPS headwind. Key risks include weather-dependent sell-through (May is pivotal), input cost inflation (notably urea) that may require future pricing, and a promotional retail environment with some private-label pressure. Overall, the positive operational execution, liquidity, and margin improvement outweigh the near-term headwinds and timing risks.View all DE:GP7 earnings summariesGP7 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€42.62
▲(18.40% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month







